Welcia Holdings Co., Ltd. (WLCGF)
USD 16.41
(0.0%)
USD 16.41
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 43.23 Billion JPY | -5.27% |
| 2023 | 45.63 Billion JPY | 6.08% |
| 2022 | 43.02 Billion JPY | 0.1% |
| 2021 | 42.97 Billion JPY | 13.68% |
| 2020 | 37.8 Billion JPY | 30.15% |
| 2019 | 29.04 Billion JPY | 0.76% |
| 2018 | 28.82 Billion JPY | 19.71% |
| 2017 | 24.08 Billion JPY | 28.37% |
| 2016 | 18.75 Billion JPY | 44.61% |
| 2015 | 12.97 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 43.23 Billion JPY | -5.27% |
| 2024 Q1 | 7.38 Billion JPY | -47.89% |
| 2024 Q4 | 12.12 Billion JPY | 90.38% |
| 2024 Q3 | 6.37 Billion JPY | -63.29% |
| 2024 Q2 | 17.35 Billion JPY | 135.04% |
| 2023 Q2 | 16.27 Billion JPY | 110.94% |
| 2023 Q1 | 7.71 Billion JPY | -41.57% |
| 2023 FY | 45.63 Billion JPY | 6.08% |
| 2023 Q4 | 14.16 Billion JPY | 89.44% |
| 2023 Q3 | 7.47 Billion JPY | -54.04% |
| 2022 Q2 | 15.45 Billion JPY | 114.13% |
| 2022 Q1 | 7.21 Billion JPY | -27.85% |
| 2022 FY | 43.02 Billion JPY | 0.1% |
| 2022 Q4 | 13.2 Billion JPY | 86.48% |
| 2022 Q3 | 7.08 Billion JPY | -54.19% |
| 2021 Q1 | 10.52 Billion JPY | -20.39% |
| 2021 Q2 | 15.95 Billion JPY | 51.57% |
| 2021 Q4 | 10 Billion JPY | 54.15% |
| 2021 FY | 42.97 Billion JPY | 13.68% |
| 2021 Q3 | 6.48 Billion JPY | -59.33% |
| 2020 FY | 37.8 Billion JPY | 30.15% |
| 2020 Q2 | 10.25 Billion JPY | 25.99% |
| 2020 Q4 | 13.22 Billion JPY | 113.58% |
| 2020 Q1 | 8.13 Billion JPY | -13.11% |
| 2020 Q3 | 6.19 Billion JPY | -39.61% |
| 2019 Q4 | 9.36 Billion JPY | 101.35% |
| 2019 FY | 29.04 Billion JPY | 0.76% |
| 2019 Q3 | 4.65 Billion JPY | -47.36% |
| 2019 Q2 | 8.83 Billion JPY | 42.62% |
| 2019 Q1 | 6.19 Billion JPY | -32.65% |
| 2018 Q2 | 8.1 Billion JPY | 27.37% |
| 2018 FY | 28.82 Billion JPY | 19.71% |
| 2018 Q4 | 9.19 Billion JPY | 78.05% |
| 2018 Q1 | 6.36 Billion JPY | -16.41% |
| 2018 Q3 | 5.16 Billion JPY | -36.24% |
| 2017 Q2 | 7.23 Billion JPY | 63.92% |
| 2017 FY | 24.08 Billion JPY | 28.37% |
| 2017 Q4 | 7.61 Billion JPY | 57.69% |
| 2017 Q3 | 4.82 Billion JPY | -33.27% |
| 2017 Q1 | 4.41 Billion JPY | -33.81% |
| 2016 Q1 | 3.11 Billion JPY | 0.0% |
| 2016 FY | 18.75 Billion JPY | 44.61% |
| 2016 Q4 | 6.66 Billion JPY | 50.71% |
| 2016 Q3 | 4.42 Billion JPY | -2.96% |
| 2016 Q2 | 4.55 Billion JPY | 46.37% |
| 2015 FY | 12.97 Billion JPY | 0.0% |
| 2015 Q2 | 3.77 Billion JPY | 17.94% |
| 2015 Q3 | 2.18 Billion JPY | -42.19% |
| 2015 Q1 | 3.19 Billion JPY | -20.14% |
| 2014 Q4 | 4 Billion JPY | 24.02% |
| 2014 Q3 | 3.23 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -261.11 USD | 16556623745.207% |
| Allstar Health Brands, Inc. | -215.75 Thousand USD | 20037643.453% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | -6826.391% |
| Café Serendipity Holdings, Inc. | -1.43 Million USD | 3012515.911% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.57 Thousand USD | 90878805.066% |
| HealthWarehouse.com, Inc. | -1.62 Million USD | 2665915.697% |
| LIGAND PHARMACEUTICAL INC | 9.82 Million USD | -440089.39% |
| MedGen, Inc. | -15.54 USD | 278191763291.763% |
| Omni Health, Inc. | 405.52 Thousand USD | -10660533.261% |
| Oxford Investments Holdings Inc. | -342.3 Thousand USD | 12629554.022% |
| Pineapple, Inc. | -1.47 Million USD | 2925786.705% |
| ScripsAmerica, Inc. | -3.8 Million USD | 1135575.392% |